DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Lifevantage Corporation (LXRX)
« Back to company indexLXRX Chatter Timeline
Stock Ticker for LXRX
Most Active Tweeters for LXRX
| User | Tweets |
|---|---|
| @AceAnalyst | 4 |
| @techNICKaltradr | 2 |
| @ZolmaxNews | 2 |
| @bulletin_en | 2 |
| @WKRBNews | 1 |
Recent Tweets for LXRX
 |
@ez_alertz $LXRX Lexicon Pharmaceuticals to Present at Upcoming Investor Conference https://t.co/Jum6EnTIAI May 23rd 2019, 7:05am |
 |
@WeekHerald Lexicon Pharmaceuticals $LXRX Downgraded by BidaskClub https://t.co/bmPqVEICfZ May 23rd 2019, 5:05am |
 |
@dispatchtribune Lexicon Pharmaceuticals $LXRX Lowered to Sell at ValuEngine https://t.co/HaJ0r4K97K May 23rd 2019, 5:05am |
 |
@AmericanBanking Lexicon Pharmaceuticals, Inc. $LXRX Receives Average Rating of “Hold” from Brokerages https://t.co/AbtbeDT9bG #stocks May 23rd 2019, 4:05am |
 |
@WKRBNews Lexicon Pharmaceuticals, Inc. $LXRX Given Average Rating of “Hold” by Analysts https://t.co/DAs0VixMRg #markets May 23rd 2019, 4:05am |
 |
@FinZTribune How Many Lexicon Pharmaceuticals, Inc. $LXRX's Analysts Are Bearish? https://t.co/gNuZ93kZNp May 22nd 2019, 7:05am |
 |
@techNICKaltradr $LXRX following that trendline perfectly... just an updated chart nothing adjusted on my end. Nearing the bigger mo… https://t.co/xujBXGHC4K May 21st 2019, 7:05pm |
 |
@ZolmaxNews Lexicon Pharmaceuticals $LXRX Lowered to “Sell” at BidaskClub https://t.co/TTTac0qM92 May 21st 2019, 7:05am |
 |
@OlympiaReport Lexicon Pharmaceuticals $LXRX Cut to “Sell” at ValuEngine https://t.co/GY3zyn8f2L May 21st 2019, 7:05am |
 |
@ChartMill $LXRX has a better Debt to Equity ratio than 98% of its industry peers. https://t.co/yigJGU4zM8 https://t.co/OcQzoycXqJ May 20th 2019, 9:05am |
 |
@AceAnalyst $LXRX My viewpoint on the CRL issued by the FDA is that of something went wrong in the back end and has nothing to… https://t.co/GEgYtp6NYZ May 19th 2019, 10:05pm |
 |
@FlyOnTheWallHQ RT @StockWatchHQ: Lexicon Pharmaceuticals $LXRX Considering Acquisition Offer From Regeneron Pharmaceuticals $REGN, Talks In Tarrytown, NY… May 19th 2019, 7:05pm |
 |
@StockWatchHQ Lexicon Pharmaceuticals $LXRX Considering Acquisition Offer From Regeneron Pharmaceuticals $REGN, Talks In Tarrytow… https://t.co/iVdlW1asaW May 18th 2019, 7:05pm |
 |
@SwingTradeBot 50 DMA Support today: $ACAD $LXRX ... https://t.co/aW7zteKP9U May 16th 2019, 12:05pm |
|
@techNICKaltradr $LXRX cyclical timing wants a move here within the next few weeks. Look at the largest breakouts in each expansion… https://t.co/i8GRmeXr4e May 16th 2019, 11:05am |
|
@AceAnalyst $LXRX today’s conference was basically a leak of what’s to come. They basically told us the drug will get approved… https://t.co/NT9Rn62POt May 16th 2019, 12:05am |
 |
@bulletin_en Reviewing Wave Life Sciences Ltd. $LXRX's results https://t.co/vrcxFLiRIF May 15th 2019, 5:05pm |
|
@AceAnalyst $LXRX Presentation today should give us some hidden secrets we have been looking for! $35 PT May 15th 2019, 2:05pm |
 |
@WatchlistN Brokerages Expect Lexicon Pharmaceuticals, Inc. $LXRX Will Announce Quarterly Sales of $24.66 Million https://t.co/2SRVWUHYtR May 14th 2019, 9:05pm |
|
@bulletin_en Halozyme Therapeutics Inc. $LXRX https://t.co/F8smqutau2 May 14th 2019, 9:05pm |
|
@AceAnalyst $LXRX Cheap right now! Adding May 13th 2019, 12:05pm |
 |
@macondailynews Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Quarterly Sales of $24.66 Million https://t.co/hrO3HznUTD May 12th 2019, 4:05pm |
 |
@TickerReport Lexicon Pharmaceuticals $LXRX Lifted to Hold at BidaskClub https://t.co/e9oFx3D8uO May 11th 2019, 3:05am |
|
@ZolmaxNews Lexicon Pharmaceuticals $LXRX Lifted to Hold at BidaskClub https://t.co/Bz38WfLUYi May 11th 2019, 3:05am |
 |
@intercooleronli Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.09 Per Share https://t.co/5vDYT2VfZV #investingnews May 10th 2019, 1:05pm |
 |
@ledgerzette Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.09 Per Share https://t.co/gCNg3mCGsT #stocks May 10th 2019, 1:05pm |
 |
@stocknewstimes Lexicon Pharmaceuticals $LXRX Upgraded at BidaskClub https://t.co/nRFXJhx65c May 10th 2019, 12:05pm |
 |
@SleekMoneycom Lexicon Pharmaceuticals $LXRX Upgraded at BidaskClub https://t.co/Od3YXc628d #investing May 10th 2019, 12:05pm |
 |
@dailypoliticaln Lexicon Pharmaceuticals $LXRX Lifted to Hold at BidaskClub https://t.co/Q8NuQgKdLo May 9th 2019, 11:05am |
|
@ez_alertz $LXRX Lexicon Pharmaceuticals to Present at Upcoming Investor Conference https://t.co/QgmY3FU3Bc May 8th 2019, 7:05am |
|
@FinZTribune Lexicon Pharmaceuticals $LXRX Shares Were Upgraded Today by BidaskScore https://t.co/2h2dy2n5N2 May 8th 2019, 12:05am |
 |
@KanandaBarrons $LXRX #Bullish trend detected last 25th April, bouncing off my trendline! Consolidated 28% Profits since that date! https://t.co/TViOtVNGj7 May 7th 2019, 12:05pm |
|
@WeekHerald FY2019 EPS Estimates for Lexicon Pharmaceuticals, Inc. $LXRX Increased by Gabelli https://t.co/BNGbwLKFer May 7th 2019, 3:05am |
|
@AmericanBanking $24.71 Million in Sales Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/t5Pz8oTDq9 #stocks May 7th 2019, 3:05am |
 |
@ConsumerFeed Lexicon Pharmaceuticals $LXRX Stock Rating Upgraded by BidaskClub https://t.co/NstamnulOF May 7th 2019, 1:05am |
 |
@StockStalk3r These are the plays I think to myself...”Self, why didn’t you buy more shares?” $LXRX May 6th 2019, 10:05am |
|
@StockStalk3r $LXRX Quietly killing it May 6th 2019, 10:05am |
|
@StockStalk3r $LXRX Moving Nicely May 6th 2019, 9:05am |
 |
@SelfThink4 $LXRX strong start early May 6th 2019, 9:05am |
|
@dailypoliticaln Lexicon Pharmaceuticals $LXRX Stock Rating Reaffirmed by Needham & Company LLC https://t.co/CyEm6gGUGa May 6th 2019, 4:05am |
|
@ZolmaxNews Lexicon Pharmaceuticals $LXRX Stock Rating Reaffirmed by Needham & Company LLC https://t.co/wpXhfGP6BF May 6th 2019, 4:05am |
|
@TickerReport Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post FY2019 Earnings of -$0.65 Per Share https://t.co/U4kPLxxqjF May 6th 2019, 3:05am |
|
@AmericanBanking Wedbush Comments on Lexicon Pharmaceuticals, Inc.’s Q2 2019 Earnings $LXRX https://t.co/YdzM3mZZGv #stocks May 6th 2019, 1:05am |
|
@dispatchtribune Wedbush Comments on Lexicon Pharmaceuticals, Inc.’s Q2 2019 Earnings $LXRX https://t.co/H2Uah2XTZR May 6th 2019, 1:05am |
 |
@TheMarketsDaily Lexicon Pharmaceuticals $LXRX Earns “Hold” Rating from Needham & Company LLC https://t.co/mjpAredlnR May 6th 2019, 12:05am |
 |
@StockNewsWires $LXRX $SRI: Here’s What Hedge Funds Think About Lexicon Pharmaceuticals …: https://t.co/Ixt9GJQyM0 May 5th 2019, 8:05pm |
|
@ChartMill A Current Ratio of 5.20 indicates that $LXRX has no problem at all paying its short term obligations.… https://t.co/IlVdo1Yxc2 May 5th 2019, 5:05pm |
|
@dailypoliticaln Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Earnings of -$0.09 Per Share https://t.co/cvr0H1bimM May 5th 2019, 2:05pm |
|
@AmericanBanking Analysts Expect Lexicon Pharmaceuticals, Inc. $LXRX Will Announce Earnings of -$0.09 Per Share https://t.co/dAxEZlW8Gc #stocks May 5th 2019, 2:05pm |
|
@SelfThink4 $LXRX like this long. Has income generating assets and p2 data coming in second half of 2019. May 4th 2019, 9:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.